Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | NOX1 | Q9Y5S8 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26216995 | 0.73 | GAA (0.39) | GAAMEN1KMT2APOLBALOX15 | |
| SCHEMBL134753 | 0.73 | GAA (0.39) | GAAMEN1KMT2APOLBALOX15 | |
| SCHEMBL11382715 | 0.73 | GAA (0.39) | GAAMEN1KMT2APOLBALOX15 | |
| SCHEMBL10497258 | 0.73 | GAA (0.39) | GAAMEN1KMT2APOLBALOX15 | |
| SCHEMBL11382719 | 0.73 | NOX1 (0.39) | GAAMEN1KMT2APOLBALOX15 | |
| SCHEMBL28387095 | 0.71 | GAA (0.38) | GAAMEN1KMT2APOLBALOX15 | |
| SCHEMBL15065849 | 0.69 | MEN1 (0.36) | GAAMEN1KMT2APOLBALOX15 | |
| SCHEMBL17433706 | 0.68 | NOX1 (0.35) | GAAMEN1KMT2APOLBALOX15 | |
| SCHEMBL1766174 | 0.66 | SNCA (0.38) | GAAMEN1KMT2APOLBALOX15 | |
| SCHEMBL16516017 | 0.65 | POLB (0.32) | GAAMEN1KMT2APOLBALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8143011-B2 | MAGE-C2 antigenic peptides and uses thereof | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 2012-03-27 | — | — | US | disclosed |
| US-20110305722-A1 | MAGE-C2 ANTIGENIC PEPTIDES AND USES THEREOF | MA WENBIN (BE) | 2011-12-15 | — | — | US | disclosed |
| US-7785881-B2 | MAGE-C2 antigenic peptides and uses thereof | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 2010-08-31 | — | — | US | disclosed |
| US-20090233315-A1 | MAGE-C2 antigenic peptides and uses therefor | MA WENBIN | 2009-09-17 | — | — | US | disclosed |
| US-20080311652-A1 | MAGE-C2 antigenic peptides and uses thereof | PEL ALINE VAN | 2008-12-18 | — | — | US | disclosed |